In a laboratory at Washington University School of Medicine in St. Louis, researchers have achieved a cellular shortcut: transforming adult human skin cells directly into spinal motor neurons in just 30 days, without passing through a stem cell phase. The work, published in the journal Cell Stem Cell, could offer a more faithful model for studying neurodegenerative diseases that strike later in life, such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy.
Instead of rewinding cells to a pluripotent state and then coaxing them forward, the team exposed skin cells to a combination of molecular cues that are abundant in the developing brain. Two short RNA molecules—microRNAs miR-9 and miR-124—were central to the process. These microRNAs, working alongside specific transcription factors, reprogrammed the cells' genetic instructions to adopt a motor neuron identity. The resulting cells not only switched on the expected genes but also exhibited functional properties similar to native mouse motor neurons, according to the researchers.
Senior author Andrew S. Yoo, whose lab led the study, emphasized that the skin cells came from healthy adults ranging from their early 20s to late 60s. "Our research revealed how small RNA molecules can work with other cell signals called transcription factors to generate specific types of neurons, in this case motor neurons," Yoo said in a press release. He added that the team hopes to extend the work to patients with motor neuron disorders, using their skin cells to model the late-onset aspects of the disease.
The approach stands out because it avoids the ethical and technical hurdles often associated with embryonic stem cells. While pluripotent stem cells can theoretically become any cell type, their use raises ethical concerns. By skipping that stage, the new technique sidesteps those issues entirely.
Why the donor's age matters
For diseases like ALS and spinal muscular atrophy, which typically manifest in adulthood, the age of the cells is critical. When researchers use induced pluripotent stem cells, they essentially reset the cells to an embryonic state, erasing the aging signatures that are relevant to late-onset conditions. Yoo likened that process to "demolishing a house and building a new one from the ground up." In contrast, the direct conversion method is more like "renovation"—the interior is changed, but the original structure, including the aging characteristics of the adult donor, remains intact.
This preservation of age-related features could make the converted neurons a more accurate platform for studying how neurodegenerative diseases progress over time. The research focused on spinal muscular atrophy, but the implications extend to other motor neuron conditions.
The technique is not limited to motor neurons. By swapping in different transcription factors, the researchers believe it could be adapted to generate other cell types, much like embryonic stem cell differentiation. However, before any clinical application, the team must determine how closely the lab-grown cells match native human motor neurons. That comparison is the next step, Yoo noted.
For now, the work represents a proof of concept—a promising start, as Yoo put it, toward better models for diseases that currently have few treatment options.
Comments
0